Labq clinical diagnostics11/8/2023 She conducted audit and service improvement projects, collaborated with biomedical scientists to validate new immunohistochemistry methods, streamlined the adoption of molecular practice in gynaecological cancer reporting, presented at central skin cancer and gynaecological cancer multidisciplinary team meetings, and provided formal educational supervision to trainees. In addition to histopathological reporting of primary and externally referred cases, Dr Sitaraaman was actively involved in teaching histopathology registrars and advanced biomedical practitioners. After completing her senior registrar rotation, she began her consultant practice at the Royal Hallamshire Hospital in April 2020, specialising in Dermatopathology and Gynaecological Pathology. She obtained her FRCPath in 2018 and completed her Master’s in Genomic Medicine in 2020 at the University of Manchester. James’s University Hospital (Leeds), Calderdale Royal Hospital (Halifax), and Bradford Royal Infirmary (Bradford). As part of her training, she has worked at the Royal Hallamshire Hospital (Sheffield), St. She is a Chair of the RCPA Chemical Pathology Advisory Committee, a Member of the RCPA Genetic Advisory Committee, AACB, and a Chair of the Precision Medicine Services at Australian Clinical Labs.Īt Clinical Labs, A/Prof Mirette Saad leads the Molecular Genetic testing for non-invasive prenatal testing (NIPT), antenatal screening, personalised drug therapy, and cancer.ĭermatopathology, gynaecological pathology and breast pathology Specialities: Anatomical Pathologyĭr Hema Sitaraaman trained in Anatomical Pathology (Histopathology) in the United Kingdom. A/P Saad received her NHMRC-sponsored PhD degree in Cancer Genetics from Melbourne University and Peter MacCallum Cancer Institute.Īlong with her teaching and research roles, A/P Saad is a registered medical practitioner with AHPRA, a Chemical Pathology Fellow (FRCPA) at the Royal College of Pathologists of Australasia, and a Member of the Australasian Association of Clinical Biochemists (MAACB). She has a Fellowship with honours in Chemical and Molecular Pathology, with a Microbiology subspeciality, from Suez Canal University, Egypt. Peri).Molecular genetics, precision medicine, cancer genetics, antenatal screening, NIPT, endocrine, fertility testing and research, medical teaching Specialities: Chemical PathologyĪssociate Professor Mirette Saad is a Consultant Chemical Pathologist and the National Director of Molecular Genetics at Australian Clinical Labs. Mischi, supported by a multidisciplinary team integrating expertise in modeling ( Dr. The main application areas are oncology, cardiovascular, gynecology-perinatology, sleep, perioperative care, neurology, and neuromuscular research. To this end, research is carried out in tight collaboration with our clinical and industrial partners. The lab positions itself on the edge between data-driven and physics-driven analysis through a continuous effort towards understanding the application domain and modeling the full measurement chain: (patho)physiological sources, sensing physics, and signal acquisition. The Biomedical Diagnostics (BM/d) Research Laboratory develops algorithms for the interpretation of biomedical signals and data acquired with a variety of sensors, ranging from ultrasound and magnetic resonance imaging, up to electrophysiological and photoplethysmographic recording.
0 Comments
Leave a Reply.AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |